Description

• A 1:1 blend of CJC-1295 No DAC (5mg) and Ipamorelin (5mg) studied for its role in regulating growth hormone (GH) secretion.
• CJC-1295 No DAC has been researched for its ability to influence GH pulses with extended activity, mimicking natural release patterns.
• Ipamorelin interacts with the ghrelin receptor, affecting GH secretion while minimizing interactions with other endocrine pathways.
• This combination has been explored for its potential impact on metabolic processes and cellular studies.
• Commonly utilized in controlled research environments to evaluate GH-related responses.